A regulatory loop composed of RAP80-HDM2-p53 provides RAP80 enhanced p53 degradation by HDM2 in response to DNA damage

被引：0
|
作者：
Menendez, Daniel [1 ]
Yan, Jun [1 ]
Yang, Xiao-Ping [1 ]
Jetten, Anton M. [1 ]
Resnick, Michael [1 ]
机构：
[1] NIEHS, NIH, POB 12233, Res Triangle Pk, NC 27709 USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
459
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors
    Lai, ZH
    Yang, T
    Kim, YB
    Sielecki, TM
    Diamond, MA
    Strack, P
    Rolfe, M
    Caligiuri, M
    Benfield, PA
    Auger, KR
    Copeland, RA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) : 14734 - 14739
  • [32] Terphenyl-based helical mimetics that disrupt the p53/HDM2 interaction
    Yin, H
    Lee, GI
    Park, HS
    Payne, GA
    Rodriguez, JM
    Sebti, SM
    Hamilton, AD
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (18) : 2704 - 2707
  • [33] Inhibition of HDM2 and activation of p53 by ribosomal protein L23
    Jin, A
    Itahana, K
    O'Keefe, K
    Zhang, Y
    MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (17) : 7669 - 7680
  • [34] p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction
    Medina-Medina, Ixaura
    Martinez-Sanchez, Mayra
    Hernandez-Monge, Jesus
    Fahraeus, Robin
    Muller, Petr
    Olivares-Illana, Vanesa
    PROTEIN SCIENCE, 2018, 27 (05) : 976 - 986
  • [35] Targeting p53, hdm2, and CD19: vaccination and immunologic strategies
    Voss, RH
    Lotz, C
    Cellary, A
    Theobald, M
    BONE MARROW TRANSPLANTATION, 2000, 25 (Suppl 2) : S43 - S45
  • [36] RNAi knockdown of HdmX or Hdm2 leads to new insights into p53 signaling
    Berberich, Steven J.
    CELL CYCLE, 2010, 9 (18) : 3640 - 3641
  • [37] Effect of linker on the binding free energy of stapled p53/HDM2 complex
    Im, Haeri
    Ham, Sihyun
    PLOS ONE, 2020, 15 (04):
  • [38] Targeting p53, hdm2, and CD19: vaccination and immunologic strategies
    R-H Voss
    C Lotz
    A Cellary
    M Theobald
    Bone Marrow Transplantation, 2000, 25 : S43 - S45
  • [39] Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells
    Grasberger, BL
    Lu, TB
    Schubert, C
    Parks, DJ
    Carver, TE
    Koblish, HK
    Cummings, MD
    LaFrance, LV
    Milkiewicz, KL
    Calvo, RR
    Maguire, D
    Lattanze, J
    Franks, CF
    Zhao, SY
    Ramachandren, K
    Bylebyl, GR
    Zhang, M
    Manthey, CL
    Petrella, EC
    Pantoliano, MW
    Deckman, IC
    Spurlino, JC
    Maroney, AC
    Tomczuk, BE
    Molloy, CJ
    Bone, RF
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) : 909 - 912
  • [40] ROS and p53 in Regulation of UVB-induced HDM2 Alternative Splicing
    Tong, Lingying
    Wu, Shiyong
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2015, 91 (01) : 221 - 224
12345